Informações:
Falhas:
ID
34330
Descrição
Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4; ODM derived from: https://clinicaltrials.gov/show/NCT01884402
Link
https://clinicaltrials.gov/show/NCT01884402
Palavras-chave
Versões (1)
- 16/01/2019 16/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
16 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hepatitis C, Chronic NCT01884402
Eligibility Hepatitis C, Chronic NCT01884402
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT01884402
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
patients with > 18 years old.
boolean
ID.2
Item
patients diagnosed with chronic hepatitis c in the presence of hcv rna in plasma that meet criteria for initiating antiviral therapy in routine clinical practice conditions.
boolean
ID.3
Item
patients genotype 1 and 4.
boolean
ID.4
Item
patients with the results of all the factors evaluable at the time of inclusion.
boolean
ID.5
Item
patients who have accepted their participation in the study through informed consent.
boolean
ID.6
Item
patients previously treated with interferon (ifn) and ribavirin (rbv).
boolean
ID.7
Item
patients with genotype 2, 3, 5 and 6.
boolean
ID.8
Item
patients with co-infection with hepatitis b.
boolean
ID.9
Item
patients with other liver diseases.
boolean
ID.10
Item
patients with any contraindications to the drugs used in the treatment of hepatitis
boolean